Gene Therapy Using Nanocarriers for Pancreatic Ductal Adenocarcinoma: Applications and Challenges in Cancer Therapeutics

Gene Therapy Using Nanocarriers for Pancreatic Ductal Adenocarcinoma: Applications and Challenges in Cancer Therapeutics

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers worldwide, and its incidence is increasing. PDAC often shows resistance to several therapeutic modalities and a higher recurrence rate after surgical treatment in the early localized stage. Combination chemotherapy in advanced...

Full description

Bibliographic Details
Main Authors: Eun-Jeong Won, Hyeji Park, Tae-Jong Yoon, Young-Seok Cho
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Pharmaceutics
Subjects:
pancreatic ductal adenocarcinoma
miRNA
siRNA
CRISPR/Cas9
nanocarrier
Online Access:https://www.mdpi.com/1999-4923/14/1/137

Similar Items

Similar Items